Initial Statement of Beneficial Ownership (3)

FORM 3	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES	OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response... 0.5
	Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

1. Name and Address of Reporting Person ^*

Moreno Brandon

2. Date of Event Requiring Statement (MM/DD/YYYY) 1/17/2019

3. Issuer Name and Ticker or Trading Symbol

Nobilis Health Corp. [HLTH]

(Last) (First) (Middle)

11700 KATY FREEWAY SUITE 300

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director _____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below)
Chief Financial Officer /

(Street)

HOUSTON, TX 77079

(City) (State) (Zip)

5. If Amendment, Date Original Filed (MM/DD/YYYY)

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	21798	D

*Table II - Derivative Securities Beneficially Owned ( e.g.* , puts, calls, warrants, options, convertible securities)**
1. Title of Derivate Security (Instr. 4)	2. Date Exercisable and Expiration Date (MM/DD/YYYY)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
1. Title of Derivate Security (Instr. 4)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	4. Conversion or Exercise Price of Derivative Security		6. Nature of Indirect Beneficial Ownership (Instr. 5)
Stock Options (Right to Buy)	5/11/2015 ⁽¹⁾	11/11/2024	Common Stock	53333	$1.19 ⁽²⁾	D
Stock Options (Right to Buy)	3/31/2016 ⁽³⁾	1/29/2026	Common Stock	25000	$1.98 ⁽⁴⁾	D
Stock Options (Right to Buy)	3/31/2017 ⁽⁵⁾	12/21/2026	Common Stock	50000	$1.92 ⁽⁶⁾	D
Stock Options (Right to Buy)	3/31/2018 ⁽⁷⁾	12/31/2027	Common Stock	75000	$1.4 ⁽⁸⁾	D
Stock Options (Right to Buy)	9/30/2018 ⁽⁹⁾	9/14/2028	Common Stock	100000	$0.84 ⁽¹⁰⁾	D
Stock Options (Right to Buy)	⁽¹¹⁾	1/17/2029	Common Stock	150000	$0.46 ⁽¹²⁾	D
Restricted Stock Units	9/13/2021	⁽¹³⁾	Common Stock	20000	⁽¹⁴⁾	D

Explanation of Responses:
(1)	The options vested as to 26,667 on May 11, 2015, 26,667 on May 11, 2016, and 26,666 on May 11, 2017. 26,667 of the options were exercised on August 17, 2015.
(2)	The options were granted at C$1.34 per share. Conversion rate on November 11, 2014 was 0.8854 [1.1294], based on the Federal Reserve Historical Rates for the Canadian Dollar.
(3)	Stock options vest in twelve equal quarterly installments, on the last date of each calendar quarter, beginning on March 31, 2016, and ending on December 31, 2018.
(4)	The options were granted at C$2.78 per share. Conversion rate on January 29, 2016 was 0.7105 [1.4074], based on the Federal Reserve Historical Rates for the Canadian Dollar.
(5)	Stock options vest in twelve equal quarterly installments, on the last date of each calendar quarter, beginning on March 31, 2017 and ending on December 31, 2019.
(6)	Stock options were granted at an exercise price of $1.92 per share (the average volume weighted average price (VWAP)for the five business day period ending on the business day prior to the date of grant).
(7)	Stock options vest in twelve equal quarterly installments, on the last date of each calendar quarter, beginning on March 31, 2018 and ending on December 31, 2020.
(8)	Stock options granted at $1.40 calculated on a five day weighted average price (VWAP)for five business days - 12/22/2017 and 12/26/2017 - 12/29/2017.
(9)	Stock options vest in twelve equal quarterly installments, on the last date of each calendar quarter, beginning on September 30, 2018 and ending on June 30, 2021.
(10)	Stock options were granted at an exercise price of $0.84 per share (the average volume weighted average price (VWAP) for the five business day period ending on the business day prior to the date of grant).
(11)	Stock options vest as to 50,000 on January 17, 2020, 50,000 on January 17, 2021, and 50,000 on January 17, 2022.
(12)	Stock options were granted at an exercise price of $0.46 per share (the average volume weighted average price (VWAP) for the five business day period ending on the business day prior to the date of grant).
(13)	None.
(14)	Each RSU represents the contingent right to receive either (i) one share of common stock upon vesting of the RSU or (ii) a cash payment in an amount equal to the U.S. Dollar equivalent of the market price per unit on the vesting date.

Reporting Owners
Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Moreno Brandon 11700 KATY FREEWAY SUITE 300 HOUSTON, TX 77079			Chief Financial Officer

Signatures
/s/ Brandon Moreno		1/22/2019
^** Signature of Reporting Person		Date

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
*	If the form is filed by more than one reporting person, see Instruction 5(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note:	File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.